Breaking Down FMC: 11 Analysts Share Their Views
During the last three months, 11 analysts shared their evaluations of FMC (NYSE:FMC), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 2 | 8 | 1 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 4 | 0 | 0 |
| 2M Ago | 0 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 2 | 1 | 0 |
Analysts have set 12-month price targets for FMC, revealing an average target of $15.91, a high estimate of $24.00, and a low estimate of $13.00. Observing a downward trend, the current average is 24.24% lower than the prior average price target of $21.00.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of FMC by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Patrick Cunningham | Citigroup | Lowers | Neutral | $14.00 | $16.00 |
| Arun Viswanathan | RBC Capital | Lowers | Sector Perform | $14.00 | $16.00 |
| Michael Sison | Wells Fargo | Lowers | Equal-Weight | $14.00 | $16.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $16.00 | $14.00 |
| Edlain Rodriguez | Mizuho | Lowers | Outperform | $21.00 | $24.00 |
| Joshua Spector | UBS | Lowers | Neutral | $15.00 | $17.00 |
| Patrick Cunningham | Citigroup | Lowers | Neutral | $14.00 | $17.00 |
| Christopher Parkinson | Mizuho | Lowers | Outperform | $24.00 | $30.00 |
| Benjamin Theurer | Barclays | Lowers | Underweight | $13.00 | $16.00 |
| Jeffrey Zekauskas | JP Morgan | Lowers | Neutral | $14.00 | $43.00 |
| Benjamin Theurer | Barclays | Lowers | Equal-Weight | $16.00 | $22.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to FMC. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FMC compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of FMC's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into FMC's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on FMC analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
About FMC
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Breaking Down FMC's Financial Performance
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3M period, FMC showcased positive performance, achieving a revenue growth rate of 99.8% as of 31 December, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: FMC's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -158.85%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): FMC's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -58.6%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): FMC's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -15.81%, the company may face hurdles in achieving optimal financial returns.
Debt Management: FMC's debt-to-equity ratio stands notably higher than the industry average, reaching 1.94. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: Simplified
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.